文献速递头颈外科

评估临床淋巴结阴性口腔鳞状细胞癌患者颈清扫质量定量指标的预后价值

Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2022-01-01

这项多中心回顾性队列研究纳入523例cT1-2N0口腔鳞状细胞癌行择区颈清扫患者,评估淋巴结检出数(LNY)、淋巴结比率(LNR)和加权LNR(wLNR)的预后价值。pN0患者LNY≤18与更差LRC和DFS相关,pN阳性患者LNR>0.06与更差LRC和DFS相关,wLNR在所有cN0患者中均为稳健预后指标。

要点

  • pN0患者LNY≤18与LRC和DFS降低显著相关。
  • pN阳性患者LNR>0.06与LRC和DFS降低显著相关。
  • wLNR风险分层一致性优于AJCC第8版淋巴结分期。

核心结论

  • 采用wLNR等纳入颈清扫质量和区域疾病负担的定量指标,可能大幅增强cT1-2N0口腔鳞状细胞癌的预后判断,提供更可靠准确的风险估计。

研究设计与样本

  • 本研究为回顾性队列研究,数据来自7家三级学术医疗中心,共纳入523例cT1-2N0口腔鳞状细胞癌行择区颈清扫的患者。

主要发现

  • 多变量分析中,pN0患者LNY≤18与LRC降低(aHR 1.53;95%CI 1.04-2.24)和DFS降低(aHR 1.46;95%CI 1.12-1.92)显著相关,pN阳性患者无此关联。
  • pN0且LNY≤18患者与pN1患者5年LRC几乎相同(69.7% vs 71.4%),5年DFS也几乎相同(58.2% vs 55.7%)。
  • pN阳性患者中,LNR>0.06与LRC降低(aHR 2.66;95%CI 1.28-5.55)和DFS降低(aHR 1.65;95%CI 1.07-2.53)显著相关。
  • wLNR在所有cN0患者中均为稳健预后变量,不受病理淋巴结状态影响。
  • wLNR阈值风险分层的乐观校正一致性在LRC(0.61 vs 0.57)和DFS(0.61 vs 0.58)上均高于AJCC第8版淋巴结分期。

关键数值与推荐

  • LNY定义为择区颈清扫检出的淋巴结数量,LNR定义为阳性淋巴结数与总LNY的比值,wLNR将LNY和LNR信息整合为单一连续指标。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: In clinically localized (T1-2) oral cavity squamous cell carcinoma (OCSCC), regional lymph node metastasis is associated with a poor prognosis. Given the high propensity of subclinical nodal disease in these patients, upfront elective neck dissections (END) for patients with clinically node-negative disease are common and associated with better outcomes. Unfortunately, even with this risk-adverse treatment paradigm, disease recurrence still occurs, and our understanding of the factors that modulate this risk and alter survival have yet to be fully elucidated. OBJECTIVE: To investigate the prognostic value of lymph node yield (LNY), lymph node ratio (LNR), and weighted LNR (wLNR) in patients with clinically node-negative T1-2 OCSCC. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, data were collected retrospectively from 7 tertiary care academic medical centers. Overall, 523 patients with cT1-2N0 OCSCC who underwent elective neck dissections after primary surgical extirpation were identified. EXPOSURES: Lymph node yield was defined as the number of lymph nodes recovered from elective neck dissection. Lymph node ratio was defined as the ratio of positive nodes against total LNY. Weighted LNR incorporated information from both LNY and LNR into a single continuous metric. MAIN OUTCOMES AND MEASURES: Locoregional control (LRC) and disease-free survival (DFS) were both evaluated using nonparametric Kaplan-Meier estimators and semiparametric Cox regression. RESULTS: On multivariable analysis, LNY less than or equal to 18 lymph nodes was found to be significantly associated with decreased LRC (aHR, 1.53; 95% CI, 1.04-2.24) and DFS (aHR, 1.46; 95% CI, 1.12-1.92) in patients with pN0 disease, but not those with pN-positive disease. Importantly, patients with pN0 disease with LNY less than or equal to 18 and those with pN1 diseasehad nearly identical 5-year LRC (69.7% vs 71.4%) and DFS (58.2% vs 55.7%). For patients with pN-positive disease, LNR greater than 0.06 was significantly associated with decreased LRC (aHR, 2.66; 95% CI, 1.28-5.55) and DFS (aHR, 1.65; 95% CI, 1.07-2.53). Overall, wLNR was a robust prognostic variable across all patients with cN0 disease, regardless of pathologic nodal status. Risk stratification via wLNR thresholds demonstrated greater optimism-corrected concordance compared with American Joint Committee on Cancer (AJCC) 8th edition nodal staging for both LRC (0.61 vs 0.57) and DFS (0.61 vs 0.58). CONCLUSIONS AND RELEVANCE: Movement toward more robust metrics that incorporate quantitative measures of neck dissection quality and regional disease burden, such as wLNR, could greatly augment prognostication in cT1-2N0 OCSCC by providing more reliable and accurate risk estimations.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Farrokhian N, Holcomb AJ, Dimon E, et al. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 36074415. doi:10.1001/jamaoto.2022.2312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。